Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Guptill, William E. | Carr, Daniel B.**;
Affiliations: Departments of Anesthesiology and Medicine, New England Medical Center and Tufts University School of Medicine, Boston, MA, USA
Correspondence: [**] Correspondence to Dr. Carr atDepartment of Anesthesiology, Box 298. New England Medical Center, 750 Washington Street, Boston, MA 02111, USA. Tel.: +1 617 636 9710; Fax: +1 617 636 9709; E-mail: [email protected]
Note: [*] Based upon a presentation at the 1998 Annual Meeting of the American Academy of Pain Medicine, San Diego, USA.
Abstract: Cancer has a profound impact upon public health throughout the world due to its prevalence and devastating morbidity and mortality (A.K. Jacox, et al. (1994) and F.M. Ferrante, et al. (1996)). For this reason, in 1980 the World Health Organization began an effort to codify prevailing approaches to cancer pain relief and to encourage implementation of these methods as health policy throughout the world. This review will summarize subsequent progress in assessing cancer pain and treating it by means of systemic and intraspinal pharmacologic management as well as nonpharmacologic interventions. Important elements of the initial pain evaluation include a detailed history, physical examination, psychosocial assessment and, when appropriate, a diagnostic plan to detect the cause of new or escalating pain. Moreover, clinicians treating cancer patients should recognize common cancer pain syndromes. Systemic pharmacologic management, the cornerstone of cancer pain management, must be individualized. The three major classes of drugs used today in the treatment of cancer pain, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvants will be discussed. The WHO three-step ladder to guide cancer pain treatment will be reviewed. The discussion will then turn to neuroaxial pharmacologic management in the treatment of refractory pain resistant to systemic drugs. Factors to consider in deciding whether to begin spinal opioid therapy will be described. Finally, nonpharmacologic management of cancer pain will be surveyed, ranging from physical and psychosocial modalities to more invasive therapies.
Keywords: cancer, pain, analgesia, opioids, anesthesia
DOI: 10.3233/BMR-1999-12202
Journal: Journal of Back and Musculoskeletal Rehabilitation, vol. 12, no. 2, pp. 89-99, 1999
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]